Navigation Links
Pharmatek Laboratories Adds Spray Drying to Drug Development Services
Date:4/25/2011

SAN DIEGO, April 25, 2011 /PRNewswire/ -- Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added spray drying to its drug formulation and manufacturing capabilities.  The company has purchased a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture.  This technology can be used for both oral and parenteral dosage forms.

"Spray drying is an integral technology in Pharmatek's toolkit for formulating insoluble compounds. The high degree of control and reduced process steps afforded by this process offer a number of advantages over other formulation techniques: enhanced robustness and reproducibility, and the ability to control and create uniform particle size and stabilize volatile and thermo-sensitive compounds," stated Jeffrey Bibbs, CEO and CSO of Pharmatek.

In addition to converting liquid solutions or suspensions into solids in a single process step, spray drying allows for swift and efficient coating of particles, creating matrices of drug and polymers (spray dried dispersion), and manufacturing of microcapsules.

"Adding spray drying to our drug development toolkit provides another degree of sophistication to Pharmatek's broad array of formulation technologies and equipment," continued Tim Scott, President of Pharmatek.  "In the end, it is all about offering our clients another approach to formulating and manufacturing their insoluble compounds."

For a complete listing of Pharmatek's equipment and capabilities, please visit www.pharmatek.com.

About Pharmatek Laboratories, Inc.

Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development for the pharmaceutical industry.  Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, stability storage and testing, and cytotoxic and high-potency development.

Statements contained in this media release which are not historical facts may constitute forward-looking statements.  All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected including sales forecasts and strategic expansion.  The trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot Rod Chemistry, Pharmatek Formulation Screening, Pharmatek University and PTEK U are all property of Pharmatek Laboratories, Inc.  Additional information about Pharmatek Laboratories may be obtained at the Web site http://www.pharmatek.com or by calling 858-805-6383.

Company Contact:
Ryan Lane, Marketing Associate
Pharmatek Laboratories, Inc.
(858) 805-6383 x284
rlane@pharmatek.com


'/>"/>
SOURCE Pharmatek Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmatek Granted Approval by the DEA for Analysis of All Controlled Substances
2. Pharmatek Laboratories Expands GMP Manufacturing Capabilities
3. Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast
4. Pharmateks Highly-Potent and Cytotoxic (HP/C) Facility Positions It as Industry Leader in Development and Manufacturing of HP/C Compounds
5. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego
6. Bedford Laboratories™ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial
7. Analytical Bio-Chemistry (ABC) Laboratories Implements eStudy™ Hosted Platform to Support its Ecotoxicology and Other Service Offerings
8. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
9. ICAP Ocean Tomo Announces Auction of Patch Based Drug Delivery and Monitoring Techniques from Entrega Laboratories, LLC
10. Applied Science Laboratories Releases Revolutionary Eye Tracking Analysis Software
11. Columbia Laboratories to Discuss Fourth Quarter and Year End 2010 Financial Results on March 10, 2011, Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016   Acsis , a ... that leading IT market research and advisory firm IDC ... the IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software ... report provides an assessment of the capabilities and business ... trace software market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/27/2016)... Inc. (Nasdaq: HOLX ) announced today ... quarter ended March 26, 2016.  GAAP diluted earnings ... non-GAAP diluted EPS of $0.47 increased 14.6%.  Revenue ... basis, and 6.3% on a constant currency basis.  ... highlighted by 14.6% growth in non-GAAP EPS," said ...
(Date:4/27/2016)... 27, 2016 Elekta today announced ... will be the focal point of seven scientific presentations ... Society for Radiotherapy & Oncology, taking place April 29 ... state-of-the-art radiotherapy system and a high-field MRI scanner with ... the patient,s anatomy in real time. The MR-linac is ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 30, 2016 , ... Mercy College is expanding its Graduate ... programs will be expanding due to high demand: Master of Business Administration (MBA), Master ... this summer. , School of Business Graduate Program Chair Dr. Ray Manganelli ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Council for Graduate Medical Education (ACGME) that it has received accreditation for its ... accreditation of three residency programs that Memorial is currently pursuing, including Pediatrics and ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... reveals that infants born with severe congenital diaphragmatic hernia have better survival rates ... with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, ...
Breaking Medicine News(10 mins):